Profile
Donald Pearl is currently the Director at Child Neurology Foundation.
Prior to this, he was the Chief Executive Officer at Aruene Corp.
in 2020 and the Vice President-Neurology at Ipsen Biopharmaceuticals, Inc. from 2014 to 2019.
Donald Pearl active positions
| Companies | Position | Start |
|---|---|---|
| Child Neurology Foundation | Director/Board Member | - |
Former positions of Donald Pearl
| Companies | Position | End |
|---|---|---|
Aruene Corp.
 Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Chief Executive Officer | 2020-07-31 |
| Ipsen Biopharmaceuticals, Inc. | Corporate Officer/Principal | 2019-03-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| Ipsen Biopharmaceuticals, Inc. | |
Aruene Corp.
Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Health Technology |
| Child Neurology Foundation |
- Stock Market
- Insiders
- Donald Pearl
